Ziekenhuis St Jansdal — Clinical Trial Site

56 Registered trials

19 Currently recruiting

Organisation

Ziekenhuis St Jansdal

Location

Harderwijk, Netherlands

Identifier

ORG-100044290

Address

Wethouder Jansenlaan 90, 3844 DG, Netherlands

Departments

Cardiologiy
Cardiology
Department of pulmonology
Hematology
Interne geneeskunde
Longgeneeskunde
Longkankercentrum
Longziekten
Lung
Lung Cancer Center
Lung Diseases
Medical Oncology
Medische Oncologie
N/A
Obstetrics & Gynaecology
Oncology
Pneumology
Poli Longgeneeskunde
Poli Longziekten
Poli Longziekten 1.42
Pulmonary Medicine
Pulmonology
Research faculty
Reumatologie
rheumatology
Ziekenhuis St Jansdal

Clinical trials at this site (56)

Search interface

Long-term Efficacy and Safety of Tozorakimab in Participants with Chronic Obstructive Pulmonary Disease with a History of Exacerbations. Ended

2022-501063-41-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2023-04-20
Phase 2 Study to Assess Efficacy and Safety of CDR132L in Patients with Reduced Left Ventricular Ejection Fraction (≤45%) After Myocardial I… Ended

2023-507569-24-00 Myocardial Infarction, Acute Heart Failure, Left Sided 4 2022-06-20
Study to assess efficacy, safety, and tolerability of Tozorakimab in patients with symptomatic chronic obstructive pulmonary disease (COPD) … Ended

2023-503571-19-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2022-01-20
Non-inferiority study of GSK3511294 (depemokimab) compared with mepolizumab or benralizumab in participants with severe asthma with an eosin… Ended

2023-510230-84-00 Severe asthma with an eosinophilic phenotype 5 2021-05-28
A Phase 3, Randomized, Double-Blind Study of Ociperlimab, an Anti-TIGIT Antibody, in Combination With Tislelizumab Compared to Pembrolizumab… Ended

2023-507317-10-00 Locally advanced, unresectable, or metastatic non small 5 2021-05-10
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Ended

2023-503673-38-00 Adults at high risk of cardiovascular events without pr 5 2019-05-24
GIVE trial (Gazyvaro In combination with VEnetoclax in Elderly CLL) Ended

2024-511048-22-00 Chronic lymphocytic leukemia 4 2016-10-27
A randomized, phase 3 trial with anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) versus placebo for patients with early stage NSCLC af… Ended

2023-509137-39-00 Stage IB (T ≥ 4 cm), II and IIIA NSCLC 5 2015-11-06